Computational methods to assist in the discovery of pharmacological chaperones for rare diseases
- PMID: 35595532
- DOI: 10.1093/bib/bbac198
Computational methods to assist in the discovery of pharmacological chaperones for rare diseases
Abstract
Pharmacological chaperones are chemical compounds able to bind proteins and stabilize them against denaturation and following degradation. Some pharmacological chaperones have been approved, or are under investigation, for the treatment of rare inborn errors of metabolism, caused by genetic mutations that often can destabilize the structure of the wild-type proteins expressed by that gene. Given that, for rare diseases, there is a general lack of pharmacological treatments, many expectations are poured out on this type of compounds. However, their discovery is not straightforward. In this review, we would like to focus on the computational methods that can assist and accelerate the search for these compounds, showing also examples in which these methods were successfully applied for the discovery of promising molecules belonging to this new category of pharmacologically active compounds.
Keywords: computational biology; molecular dynamics simulations; pharmacological chaperones; rare diseases; stability; virtual screening.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Pharmacological Chaperones and Protein Conformational Diseases: Approaches of Computational Structural Biology.Int J Mol Sci. 2023 Mar 18;24(6):5819. doi: 10.3390/ijms24065819. Int J Mol Sci. 2023. PMID: 36982893 Free PMC article. Review.
-
Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein.Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11007-12. doi: 10.1073/pnas.1320556111. Epub 2014 Jul 14. Proc Natl Acad Sci U S A. 2014. PMID: 25024216 Free PMC article.
-
Screening methods for identifying pharmacological chaperones.Mol Biosyst. 2017 Mar 28;13(4):638-647. doi: 10.1039/c6mb00866f. Mol Biosyst. 2017. PMID: 28265599 Review.
-
Early Stage Discovery and Validation of Pharmacological Chaperones for the Correction of Protein Misfolding Diseases.Methods Mol Biol. 2019;1873:279-292. doi: 10.1007/978-1-4939-8820-4_18. Methods Mol Biol. 2019. PMID: 30341617
-
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study.Orphanet J Rare Dis. 2010 Dec 7;5:36. doi: 10.1186/1750-1172-5-36. Orphanet J Rare Dis. 2010. PMID: 21138548 Free PMC article.
Cited by
-
Computational model for drug research.Brief Bioinform. 2024 Mar 27;25(3):bbae158. doi: 10.1093/bib/bbae158. Brief Bioinform. 2024. PMID: 38581423 Free PMC article.
-
Improvement of Mutant Galactose-1-Phosphate Uridylyltransferase (GALT) Activity by FDA-Approved Pharmacochaperones: A Preliminary Study.Int J Mol Sci. 2025 Jan 21;26(3):888. doi: 10.3390/ijms26030888. Int J Mol Sci. 2025. PMID: 39940658 Free PMC article.
-
Applications of machine learning in computer-aided drug discovery.QRB Discov. 2022 Sep 1;3:e14. doi: 10.1017/qrd.2022.12. eCollection 2022. QRB Discov. 2022. PMID: 37529294 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical